quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 22, 2026

Americans would get ‘universal high income’ via steady federal checks under Elon Musk’s new proposal. Will it happen?

View original at finance.yahoo.com
Americans would get ‘universal high income’ via steady federal checks under Elon Musk’s new proposal. Will it happen? Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Advances in automation and productivity could dramatically increase the supply of goods and services, potentially offsetting inflationary pressure from increased money circulation

    60% confidence

  • AI and robotics will produce goods and services far in excess of the increase in the money supply, so there will not be inflation

    60% confidence

  • Universal HIGH INCOME via checks issued by the Federal government is the best way to deal with unemployment caused by AI

    60% confidence

  • AI was linked to nearly 55,000 job cuts in the U.S. in 2025

    60% confidence

  • Roughly 30,000 additional jobs have already been lost to AI in early 2026

    60% confidence

Data points we hold from this source

Elon Musk · social media post comments46000 comments
Elon Musk · social media post likes195000 likes
Elon Musk · social media post views68000000 views
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Americans would get ‘universal high income’ via steady federal checks under Elon Musk’s new proposal. Will it happen? — Source | Via News | pt.VIA.NEWS